Global Newborn Screening Testing Market Overview:
Global Newborn Screening Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Newborn Screening Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Newborn Screening Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Newborn Screening Testing Market:
The Newborn Screening Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Newborn Screening Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Newborn Screening Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Newborn Screening Testing market has been segmented into:
Blood Spot Test
Hearing Screening
Critical Congenital Heart Disease Screening
Urine Screening
Genetic Screening
By Application, Newborn Screening Testing market has been segmented into:
Instruments
Reagents
Sample Collection Devices
Software
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Newborn Screening Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Newborn Screening Testing market.
Top Key Players Covered in Newborn Screening Testing market are:
Ginkgo BioWorks
Thermo Fisher Scientific
Abbott Laboratories
BioRad Laboratories
LifeLabs
Neogen
PerkinElmer
NantHealth
Roche
Grifols
Agilent Technologies
ScanBalt
Boulevard Diagnostic
Hematologic Technologies
Siemens Healthineers
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Newborn Screening Testing Market Type
4.1 Newborn Screening Testing Market Snapshot and Growth Engine
4.2 Newborn Screening Testing Market Overview
4.3 Blood Spot Test
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Blood Spot Test: Geographic Segmentation Analysis
4.4 Hearing Screening
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Hearing Screening: Geographic Segmentation Analysis
4.5 Critical Congenital Heart Disease Screening
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Critical Congenital Heart Disease Screening: Geographic Segmentation Analysis
4.6 Urine Screening
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Urine Screening: Geographic Segmentation Analysis
4.7 Genetic Screening
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Genetic Screening: Geographic Segmentation Analysis
Chapter 5: Newborn Screening Testing Market Application
5.1 Newborn Screening Testing Market Snapshot and Growth Engine
5.2 Newborn Screening Testing Market Overview
5.3 Instruments
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Instruments: Geographic Segmentation Analysis
5.4 Reagents
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Reagents: Geographic Segmentation Analysis
5.5 Sample Collection Devices
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Sample Collection Devices: Geographic Segmentation Analysis
5.6 Software
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Software: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Newborn Screening Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GINKGO BIOWORKS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 THERMO FISHER SCIENTIFIC
6.4 ABBOTT LABORATORIES
6.5 BIORAD LABORATORIES
6.6 LIFELABS
6.7 NEOGEN
6.8 PERKINELMER
6.9 NANTHEALTH
6.10 ROCHE
6.11 GRIFOLS
6.12 AGILENT TECHNOLOGIES
6.13 SCANBALT
6.14 BOULEVARD DIAGNOSTIC
6.15 HEMATOLOGIC TECHNOLOGIES
6.16 SIEMENS HEALTHINEERS
Chapter 7: Global Newborn Screening Testing Market By Region
7.1 Overview
7.2. North America Newborn Screening Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Blood Spot Test
7.2.2.2 Hearing Screening
7.2.2.3 Critical Congenital Heart Disease Screening
7.2.2.4 Urine Screening
7.2.2.5 Genetic Screening
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Instruments
7.2.3.2 Reagents
7.2.3.3 Sample Collection Devices
7.2.3.4 Software
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Newborn Screening Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Blood Spot Test
7.3.2.2 Hearing Screening
7.3.2.3 Critical Congenital Heart Disease Screening
7.3.2.4 Urine Screening
7.3.2.5 Genetic Screening
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Instruments
7.3.3.2 Reagents
7.3.3.3 Sample Collection Devices
7.3.3.4 Software
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Newborn Screening Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Blood Spot Test
7.4.2.2 Hearing Screening
7.4.2.3 Critical Congenital Heart Disease Screening
7.4.2.4 Urine Screening
7.4.2.5 Genetic Screening
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Instruments
7.4.3.2 Reagents
7.4.3.3 Sample Collection Devices
7.4.3.4 Software
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Newborn Screening Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Blood Spot Test
7.5.2.2 Hearing Screening
7.5.2.3 Critical Congenital Heart Disease Screening
7.5.2.4 Urine Screening
7.5.2.5 Genetic Screening
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Instruments
7.5.3.2 Reagents
7.5.3.3 Sample Collection Devices
7.5.3.4 Software
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Newborn Screening Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Blood Spot Test
7.6.2.2 Hearing Screening
7.6.2.3 Critical Congenital Heart Disease Screening
7.6.2.4 Urine Screening
7.6.2.5 Genetic Screening
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Instruments
7.6.3.2 Reagents
7.6.3.3 Sample Collection Devices
7.6.3.4 Software
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Newborn Screening Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Blood Spot Test
7.7.2.2 Hearing Screening
7.7.2.3 Critical Congenital Heart Disease Screening
7.7.2.4 Urine Screening
7.7.2.5 Genetic Screening
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Instruments
7.7.3.2 Reagents
7.7.3.3 Sample Collection Devices
7.7.3.4 Software
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Newborn Screening Testing Scope:
|
Report Data
|
Newborn Screening Testing Market
|
|
Newborn Screening Testing Market Size in 2025
|
USD XX million
|
|
Newborn Screening Testing CAGR 2025 - 2032
|
XX%
|
|
Newborn Screening Testing Base Year
|
2024
|
|
Newborn Screening Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Ginkgo BioWorks, Thermo Fisher Scientific, Abbott Laboratories, BioRad Laboratories, LifeLabs, Neogen, PerkinElmer, NantHealth, Roche, Grifols, Agilent Technologies, ScanBalt, Boulevard Diagnostic, Hematologic Technologies, Siemens Healthineers.
|
|
Key Segments
|
By Type
Blood Spot Test
Hearing Screening
Critical Congenital Heart Disease Screening
Urine Screening
Genetic Screening
By Applications
Instruments
Reagents
Sample Collection Devices
Software
|
